OB/GYN Clinical Alert – March 1, 2013

March 1, 2013

• Weight Gain with Contraception

  The authors performed a two-part analysis of the contraceptive choice Project, a prospective cohort study in which women in the St. Louis, Missouri, region received a reversible contraceptive method of their choice for up to 3 years at no cost.

  Read more

• "Off-target"; Effects? The Role of Statins in Cancer Biology

  Cholesterol-reducing statin agents have been associated preclinically with cancer cell growth inhibition and metastases prevention.

  Read more

• Risk of Uterine Rupture or Placenta Previa after Previous Myomectomy or Classical Cesarean

  Conventional wisdom in obstetrics implies that woen with previous uterine surgery outside the lower uterine segment — whether myomectomy or classical cesarean section — incrue an unacceptable risk for uterine rupture during pregnancy.

  Read more

• Testosterone — It’s Not the Magic Bullet

  1998 was a landmark year for men’s sexuality. the FDA approved sildenafil (Viagra®), a medication that now has household name familiarity.

  Read more

• Pharmacology Watch: Aspirin Use and Age-Related Macular Degeneration

  In this issue: Aspirin use and AMD risk; using NSAIDs and antihypertensive agents; and FDA actions.

  Read more

• Clinical Briefs in Primary Care supplement

  Read more